What is Citigroup's price target for ACAD?

Citigroup's latest stated price target for ACADIA Pharmaceuticals Inc. (ACAD) is $33, from its action on Oct 21, 2025.

What is Citigroup's rating on ACAD?

Citigroup rates ACAD Buy, a bullish rating, as of Oct 21, 2025.

When did Citigroup last change its view on ACAD?

On Oct 21, 2025, Citigroup starts coverage at Buy, price target $33.

Citigroup ACAD price target and rating history

ACADIA Pharmaceuticals Inc. (ACAD) · Health Care

Citigroup rates ACADIA Pharmaceuticals Inc. (ACAD) Buy with a $33 price target, as of its latest action on Oct 21, 2025. It has published 7 rating actions on ACAD since December 2021, including 1 upgrade and 2 downgrades. Across 4 firms with a ACAD price target in the last 12 months, the median target is $31.

Current rating: Buy
Price target: $33
Median target, all firms: $31
Actions on ACAD: 7

Citigroup price target on ACAD

Citigroup price target on ACAD, each point a stated target, December 2021 to October 2025.

Every Citigroup rating on ACAD

Oct 21, 2025
InitiateCitigroup starts coverage at Buy, price target $33
Dec 13, 2023
InitiateCitigroup starts coverage at Buy, price target $38
Aug 8, 2022
DowngradeCitigroup downgrades to Neutral from Buy, price target $19 to $15
Aug 5, 2022
DowngradeCitigroup downgrades to Neutral from Buy, price target $19 to $15
Jan 5, 2022
UpgradeCitigroup upgrades to Buy from Neutral, price target $30
Dec 21, 2021
ReiterateCitigroup raises its price target to $30 from $28, keeps Neutral
Dec 7, 2021
ReiterateCitigroup raises its price target to $28 from $25, keeps Neutral

How other firms rate ACAD

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
UBS	Neutral	$23	Oct 13, 2026
BofA Securities	Buy	$29	Mar 25, 2026
Wolfe Research	Outperform	$33	Feb 24, 2026
Mizuho	Outperform	$35	Feb 23, 2026

Questions about Citigroup and ACAD

What is Citigroup's price target for ACAD?: Citigroup's latest stated price target for ACADIA Pharmaceuticals Inc. (ACAD) is $33, from its action on Oct 21, 2025.
What is Citigroup's rating on ACAD?: Citigroup rates ACAD Buy, a bullish rating, as of Oct 21, 2025.
When did Citigroup last change its view on ACAD?: On Oct 21, 2025, Citigroup starts coverage at Buy, price target $33.
How does Citigroup's ACAD target compare with other analysts?: Across 4 firms with a ACAD price target in the last 12 months, the median target is $31.

More ACAD rating histories

All Citigroup ratings ACAD news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.